PaireOB Plus DHA 200 mg DHA Gel Capsule

Lactating Pregnant Women Adult Female (18 - 50 Years) NP Maternal Nutritional Supplement How supplied: Paire OB Plus DHA is supplied in six child-resistant blister packs of 5 tablets and 5 capsules each- NDC 11528-095-03. In child-resistant blister packaging Contains six 5-day blister packs NDC 11528-095-03 Rx Only See current USP Storage: Store at controlled room temperature 20 degrees-25 degrees Celsius (68 degrees-77 degrees Fahrenheit). Excursions permitted to 15 degrees-30 degrees Celsius (59 degrees-86 degrees Fahrenheit). Dosage and administration: One tablet and one softgel daily with or without food, or as prescribed by a licensed health care provider with prescribing authority.

An Rx Prenatal Vitamin and Omega-3 Docosahexaenoic Acid (DHA) Rx prenatal vitamin tablet and 200 mg DHA gel capsule Description: Paire OB Plus DHA is a prescription prenatal/postnatal multivitamin/mineral tablet and a gel capsule of an essential fatty acid. Gel capsules contain a highly purified pharmaceutical grade DHA Indication and usage: Paire OB Plus DHA is a prescription multivitamin/multimineral and Omega-3 fatty acid nutritional supplement indicated for use in improving the nutritional status of women throughout pregnancy and in postnatal period for both lactating and non-lactating mothers. Paire OB Plus DHA is also beneficial in improving the nutritional status of women prior to conception. Contact with moisture can discolor or erode the tablet. The enclosed highly purified, pharmaceutical grade DHA capsules were manufactured using a 7-step refining process that meets the standards of the Global Organization for DHA Omega 3s. The essential fatty acid DHA capsule is a softgel containing a clear semi-solid mixture.

Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Warning: Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited of acquired predisposition to bleeding diathesis. Keep out of reach of children.